Persistent Asset Partners »

Arrivent Biopharma shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $160k 8.0k 20.12

More positions owned by Persistent Asset Partners

Centene Corporation (CNC)
Molina Healthcare (MOH)
Anthem (ELV)
Intel Corporation (INTC)
Axt (AXTI)
Terns Pharmaceuticals (TERN)
Sandisk Corp (SNDK)
Abivax Sa Sponsored Ads (ABVX)
Johnson & Johnson (JNJ)
Brightspring Health Svcs (BTSG)
Viking Therapeutics Call Call Option
Viking Therapeutics (VKTX)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Nebius Group Shs Class A (NBIS)

View all positions for Persistent Asset Partners

Top funds holding Arrivent Biopharma

Infinitum Asset Management
Suvretta Capital Management
Hillhouse Capital Advisors
FMR
OrbiMed Advisors
BlackRock
Octagon Capital Advisors
Novo A/S
Vanguard Group
Sofinnova Ventures
General Catalyst Group Management
State Street Corporation
Geode Capital Management
Goldman Sachs Group
Sc China Holding

View all funds holding Arrivent Biopharma